Literature DB >> 7684739

Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.

J K Bubien1, L J Zhou, P D Bell, R A Frizzell, T F Tedder.   

Abstract

CD20 is a plasma membrane phosphoprotein expressed exclusively by B lymphocytes. mAb binding to CD20 alters cell cycle progression and differentiation, indicating that CD20 plays an essential role in B lymphocyte function. Whole-cell patch clamp and fluorescence microscopy measurements of plasma membrane ionic conductance and cytosolic-free Ca2+ activity, respectively, were used to directly examine CD20 function. Transfection of human T and mouse pre-B lymphoblastoid cell lines with CD20 cDNA and subsequent stable expression of CD20 specifically increased transmembrane Ca2+ conductance. Transfection of CD20 cDNA and subsequent expression of CD20 in nonlymphoid cells (human K562 erythroleukemia cells and mouse NIH-3T3 fibroblasts) also induced the expression of an identical transmembrane Ca2+ conductance. The binding of a CD20-specific mAb to CD20+ lymphoblastoid cells also enhanced the transmembrane Ca2+ conductance. The mAb-enhanced Ca2+ currents had the same conductance characteristics as the CD20-associated Ca2+ currents in CD20 cDNA-transfected cells. C20 is structurally similar to several ion channels; each CD20 monomer possesses four membrane spanning domains, and both the amino and carboxy termini reside within the cytoplasm. Biochemical cross-linking of cell-surface molecules with subsequent immunoprecipitation analysis of CD20 suggests that CD20 may be present as a multimeric oligomer within the membrane, as occurs with several known membrane channels. Taken together, these findings indicate that CD20 directly regulates transmembrane Ca2+ conductance in B lymphocytes, and suggest that multimeric complexes of CD20 may form Ca2+ conductive ion channels in the plasma membrane of B lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684739      PMCID: PMC2119683          DOI: 10.1083/jcb.121.5.1121

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  54 in total

1.  IgE-mediated degranulation of mast cells does not require opening of ion channels.

Authors:  M Lindau; J M Fernandez
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

2.  Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes.

Authors:  T F Tedder; A Forsgren; A W Boyd; L M Nadler; S F Schlossman
Journal:  Eur J Immunol       Date:  1986-08       Impact factor: 5.532

3.  Topological analysis of the major protein in isolated intact rat liver gap junctions and gap junction-derived single membrane structures.

Authors:  D B Zimmer; C R Green; W H Evans; N B Gilula
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

4.  Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel.

Authors:  V Flockerzi; H J Oeken; F Hofmann; D Pelzer; A Cavalié; W Trautwein
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

5.  Expression of functional sodium channels from cloned cDNA.

Authors:  M Noda; T Ikeda; H Suzuki; H Takeshima; T Takahashi; M Kuno; S Numa
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

6.  Role of the Bp35 cell surface polypeptide in human B-cell activation.

Authors:  E A Clark; G Shu; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Further biochemical studies of the human B-cell differentiation antigens B1 and B2.

Authors:  H C Oettgen; P J Bayard; W Van Ewijk; L M Nadler; C P Terhorst
Journal:  Hybridoma       Date:  1983

8.  Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins.

Authors:  J M Lambert; P D Senter; A Yau-Young; W A Blättler; V S Goldmacher
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

9.  The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle.

Authors:  J T Golay; E A Clark; P C Beverley
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.

Authors:  E Smeland; T Godal; E Ruud; K Beiske; S Funderud; E A Clark; S Pfeifer-Ohlsson; R Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more
  74 in total

Review 1.  Calcium channels in lymphocytes.

Authors:  G Grafton; L Thwaite
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

Review 2.  CD20-mediated apoptosis: signalling through lipid rafts.

Authors:  Julie P Deans; Haidong Li; Maria J Polyak
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

Review 3.  Lipid raft: A floating island of death or survival.

Authors:  Kimberly S George; Shiyong Wu
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-24       Impact factor: 4.219

4.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

Review 5.  The MS4A family: counting past 1, 2 and 3.

Authors:  Li Eon Kuek; Melanie Leffler; Graham A Mackay; Mark D Hulett
Journal:  Immunol Cell Biol       Date:  2015-04-03       Impact factor: 5.126

6.  Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis.

Authors:  E Janas; R Priest; J I Wilde; J H White; R Malhotra
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

7.  Guillain-Barre syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyond anecdotal evidence?

Authors:  Alberto Carmona; Juan Domingo Alonso; Manuel de las Heras; Agustín Navarrete
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

Review 8.  Treatment with rituximab in benign and malignant hematologic disorders in children.

Authors:  Lisa B Giulino; James B Bussel; Ellis J Neufeld
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

9.  The FcεRIβ homologue, MS4A4A, promotes FcεRI signal transduction and store-operated Ca2+ entry in human mast cells.

Authors:  Greer K Arthur; Lauren C Ehrhardt-Humbert; Douglas B Snider; Corey Jania; Stephen L Tilley; Dean D Metcalfe; Glenn Cruse
Journal:  Cell Signal       Date:  2020-03-30       Impact factor: 4.315

Review 10.  B cells and their mediators as targets for therapy in solid tumors.

Authors:  Andrew J Gunderson; Lisa M Coussens
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.